Pretium is a research, disease management and health economics organisation developed to support research and commercialisation objectives for the pharmaceutical and biotech industries. Our highly experienced and qualified staff and consultants provide a unique integration of skills, expertise and innovation that delivers results. Pretium provides market intelligence services, ranging from development of market access strategies and programs, market research, elicitation of expert opinion to the development of value dossiers and PBAC submissions. Pretium custom develops and executes disease management programs including patient support programs, nurse-facilitated patient assessment and management programs, adherence programs and clinical audit programs. Our primary care network serves as an excellent platform for phase IV clinical studies and post-marketing research. The breadth and depth of our knowledge and experience provides an ideal partner for your marketing needs.